BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 26619963)

  • 21. ADAMDEC1 induces EMT and promotes colorectal cancer cells metastasis by enhancing Wnt/β-catenin signaling via negative modulation of GSK-3β.
    Jia Y; Huang X; Shi H; Wang M; Chen J; Zhang H; Hou D; Jing H; Du J; Han H; Zhang J
    Exp Cell Res; 2023 Aug; 429(2):113629. PubMed ID: 37187249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation.
    Akiyoshi T; Nakamura M; Koga K; Nakashima H; Yao T; Tsuneyoshi M; Tanaka M; Katano M
    Gut; 2006 Jul; 55(7):991-9. PubMed ID: 16299030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced expression of beta-catenin inhibitor Chibby in colon carcinoma cell lines.
    Schuierer MM; Graf E; Takemaru K; Dietmaier W; Bosserhoff AK
    World J Gastroenterol; 2006 Mar; 12(10):1529-35. PubMed ID: 16570344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway.
    Liu X; Su K; Sun X; Jiang Y; Wang L; Hu C; Zhang C; Lu M; Du X; Xing B
    J Exp Clin Cancer Res; 2021 Apr; 40(1):132. PubMed ID: 33858476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The oncogenic function of PLAGL2 is mediated via ASCL2 and IGF2 and a Wnt-independent mechanism in colorectal cancer.
    Fischer AD; Veronese Paniagua DA; Swaminathan S; Kashima H; Rubin DC; Madison BB
    Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G196-G211. PubMed ID: 37310750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice.
    Yuan K; Xie K; Fox J; Zeng H; Gao H; Huang C; Wu M
    Gastroenterology; 2013 Oct; 145(4):853-64.e9. PubMed ID: 23770133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel RIP1-mediated canonical WNT signaling pathway that promotes colorectal cancer metastasis via β -catenin stabilization-induced EMT.
    Kang AR; Kim JL; Kim Y; Kang S; Oh SC; Park JK
    Cancer Gene Ther; 2023 Oct; 30(10):1403-1413. PubMed ID: 37500894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
    Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE
    BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer.
    Sun Z; Ou C; Liu J; Chen C; Zhou Q; Yang S; Li G; Wang G; Song J; Li Z; Zhang Z; Yuan W; Li X
    Oncogene; 2019 Apr; 38(14):2627-2644. PubMed ID: 30531836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vimentin affects colorectal cancer proliferation, invasion, and migration via regulated by activator protein 1.
    Wang Q; Zhu G; Lin C; Lin P; Chen H; He R; Huang Y; Yang S; Ye J
    J Cell Physiol; 2021 Nov; 236(11):7591-7604. PubMed ID: 34041752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PI3K/Akt/GSK-3β signal pathway is involved in P2X7 receptor-induced proliferation and EMT of colorectal cancer cells.
    Zhang WJ; Luo C; Huang C; Pu FQ; Zhu JF; Zhu ZM
    Eur J Pharmacol; 2021 May; 899():174041. PubMed ID: 33737010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BTF3-mediated regulation of BMI1 promotes colorectal cancer through influencing epithelial-mesenchymal transition and stem cell-like traits.
    Zhou W; Yun Z; Wang T; Li C; Zhang J
    Int J Biol Macromol; 2021 Sep; 187():800-810. PubMed ID: 34293363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation.
    Jung C; Kim RS; Zhang H; Lee SJ; Sheng H; Loehrer PJ; Gardner TA; Jeng MH; Kao C
    Br J Cancer; 2005 Jun; 92(12):2233-9. PubMed ID: 15928669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells.
    Hawcroft G; D'Amico M; Albanese C; Markham AF; Pestell RG; Hull MA
    Carcinogenesis; 2002 Jan; 23(1):107-14. PubMed ID: 11756231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cMET promotes metastasis and epithelial-mesenchymal transition in colorectal carcinoma by repressing RKIP.
    Wang S; Ma H; Yan Y; Chen Y; Fu S; Wang J; Wang Y; Chen H; Liu J
    J Cell Physiol; 2021 May; 236(5):3963-3978. PubMed ID: 33151569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B7-H4 induces epithelial-mesenchymal transition and promotes colorectal cancer stemness.
    Feng Y; Yang Z; Zhang C; Che N; Liu X; Xuan Y
    Pathol Res Pract; 2021 Feb; 218():153323. PubMed ID: 33429327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity.
    Noah TK; Lo YH; Price A; Chen G; King E; Washington MK; Aronow BJ; Shroyer NF
    Gastroenterology; 2013 May; 144(5):1012-1023.e6. PubMed ID: 23376423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KLF3 Transcription Activates WNT1 and Promotes the Growth and Metastasis of Gastric Cancer via Activation of the WNT/β-Catenin Signaling Pathway.
    Li Y; Wang Y; Zou Q; Li S; Zhang F
    Lab Invest; 2023 Jun; 103(6):100078. PubMed ID: 36827869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patients.
    Savio AJ; Daftary D; Dicks E; Buchanan DD; Parfrey PS; Young JP; Weisenberger D; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B
    BMC Cancer; 2016 Feb; 16():113. PubMed ID: 26884349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LINC00982-encoded protein PRDM16-DT regulates
    Hu HF; Han L; Fu JY; He X; Tan JF; Chen QP; Han JR; He QY
    Theranostics; 2024; 14(8):3317-3338. PubMed ID: 38855188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.